Mpm Bioimpact LLC

Mpm Bioimpact LLC reported 37 holdings worth US$1.35B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Mpm Bioimpact LLC reported 37 holdings worth US$1.35B as of Sep 30, 2026. Largest: Cullinan Therapeutics, Inc., Aktis Oncology, Inc. and Travere Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
37
Value as reported
US$1.35B

The filing in full

CompanySharesValue as reported% of portfolio
Cullinan Therapeutics, Inc.9.72MUS$149M11.1%
Aktis Oncology, Inc.4.84MUS$94.2M7.0%
Travere Therapeutics, Inc.1.09MUS$64.1M4.8%
Edgewise Therapeutics, Inc.1.58MUS$64M4.7%
Dyne Therapeutics, Inc.3.21MUS$51.7M3.8%
Corcept Therapeutics Incorporated422KUS$48.6M3.6%
Relay Therapeutics, Inc.2.37MUS$42.8M3.2%
Trevi Therapeutics, Inc.2.98MUS$42.7M3.2%
Iovance Biotherapeutics, Inc.2.84MUS$42M3.1%
Liquidia Corporation1.34MUS$40.6M3.0%
Natera, Inc.90,585US$37.4M2.8%
Immunocore Holdings plc1.2MUS$36.4M2.7%
DBV Technologies SA3.04MUS$35.8M2.7%
Taysha Gene Therapies, Inc.7.26MUS$35.4M2.6%
Abivax SA328KUS$32.5M2.4%
Vir Biotechnology, Inc.2.81MUS$31.4M2.3%
Adlai Nortye Group Ltd.1.96MUS$31.3M2.3%
Verastem, Inc.3.85MUS$31M2.3%
Odyssey Therapeutics, Inc.1.29MUS$28.6M2.1%
Tarsus Pharmaceuticals, Inc.353KUS$27.7M2.1%
Palvella Therapeutics, Inc.198KUS$27.3M2.0%
Aclaris Therapeutics, Inc.5.18MUS$27.2M2.0%
Oruka Therapeutics, Inc.300KUS$25M1.9%
ORIC Pharmaceuticals, Inc.1.82MUS$24.5M1.8%
Stoke Therapeutics, Inc.925KUS$24.1M1.8%
Belite Bio, Inc.133KUS$22.7M1.7%
Neurogene Inc.772KUS$21.5M1.6%
Zura Bio Limited4.45MUS$18.5M1.4%
Annexon, Inc.4.29MUS$18.1M1.3%
Monte Rosa Therapeutics, Inc.1.13MUS$13.4M1.00%
BioAge Labs, Inc.1.86MUS$13.2M0.98%
Corbus Pharmaceuticals Holdings, Inc.1.67MUS$11.4M0.84%
Bright Minds Biosciences Inc.196KUS$9.75M0.72%
First Tracks Biotherapeutics, Inc.254KUS$9.02M0.67%
Entrada Therapeutics, Inc.0US$00.00%
Forte Biosciences, Inc.0US$00.00%
Revolution Medicines, Inc.0US$00.00%
Syndax Pharmaceuticals, Inc.0US$00.00%
Ultragenyx Pharmaceutical Inc.0US$00.00%
Werewolf Therapeutics, Inc.0US$00.00%
Alumis Inc.0US$00.00%
Context Therapeutics Inc.0US$00.00%
Dianthus Therapeutics, Inc.0US$00.00%

Source

Download original · View original at SEC

Related